Jiangsu Kanion Pharmaceutical Co.Ltd(600557) : net profit in 2021 increased by 21.92% year on year

Jiangsu Kanion Pharmaceutical Co.Ltd(600557) ( Jiangsu Kanion Pharmaceutical Co.Ltd(600557) ) disclosed the annual report on March 3, and realized an operating revenue of 3.649 billion yuan in 2021, with a year-on-year increase of 20.34%; The net profit was 321 million yuan, a year-on-year increase of 21.92%. The basic earnings per share is 0.56 yuan. During the reporting period, ginkgo diterpene lactone glucosamine injection, Jinzhen oral liquid, Xingbei Zhike granules and other varieties overcame the impact of the epidemic and achieved rapid growth.